
### [MONDO:0019053](http://purl.obolibrary.org/obo/MONDO_0019053)
**Label:** peroxisomal disease

**Subclasses:** [MONDO:0017986](http://purl.obolibrary.org/obo/MONDO_0017986) (disorder of plasmalogens biosynthesis), [MONDO:0017753](http://purl.obolibrary.org/obo/MONDO_0017753) (disorder of peroxisomal alpha-, beta- and omega-oxidation), [MONDO:0015776](http://purl.obolibrary.org/obo/MONDO_0015776) (rhizomelic chondrodysplasia punctata), [MONDO:0018598](http://purl.obolibrary.org/obo/MONDO_0018598) (neonatal adrenoleukodystrophy), [MONDO:0011101](http://purl.obolibrary.org/obo/MONDO_0011101) (peroxisome biogenesis disorder 1B), [MONDO:0018544](http://purl.obolibrary.org/obo/MONDO_0018544) (X-linked adrenoleukodystrophy), [MONDO:0019234](http://purl.obolibrary.org/obo/MONDO_0019234) (peroxisome biogenesis disorder), [MONDO:0019233](http://purl.obolibrary.org/obo/MONDO_0019233) (peroxisomal beta-oxidation disorder), [MONDO:0019174](http://purl.obolibrary.org/obo/MONDO_0019174) (infantile Refsum disease), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0009958](http://purl.obolibrary.org/obo/MONDO_0009958) (Refsum disease), [MONDO:0010247](http://purl.obolibrary.org/obo/MONDO_0010247) (X-linked cerebral adrenoleukodystrophy), [MONDO:0019609](http://purl.obolibrary.org/obo/MONDO_0019609) (Zellweger syndrome), 

**Corr. equiv. classes:** [Orphanet:177](http://www.orpha.net/ORDO/Orphanet_177), [Orphanet:44](http://www.orpha.net/ORDO/Orphanet_44), [Orphanet:773](http://www.orpha.net/ORDO/Orphanet_773), [Orphanet:772](http://www.orpha.net/ORDO/Orphanet_772), [OMIM:300100](http://purl.obolibrary.org/obo/OMIM_300100), [Orphanet:43](http://www.orpha.net/ORDO/Orphanet_43), [OMIM:266500](http://purl.obolibrary.org/obo/OMIM_266500), [Orphanet:309810](http://www.orpha.net/ORDO/Orphanet_309810), [OMIM:601539](http://purl.obolibrary.org/obo/OMIM_601539), [Orphanet:139396](http://www.orpha.net/ORDO/Orphanet_139396), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), [Orphanet:3276](http://www.orpha.net/ORDO/Orphanet_3276), [Orphanet:912](http://www.orpha.net/ORDO/Orphanet_912), [Orphanet:79188](http://www.orpha.net/ORDO/Orphanet_79188), [Orphanet:79189](http://www.orpha.net/ORDO/Orphanet_79189), 

**Class expressions from DL-Learner:**

- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 62.50%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) 62.50%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) 62.50%
- [HP:0000598](http://purl.obolibrary.org/obo/HP_0000598) (Abnormality of the ear) and [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) 62.50%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) 62.50%
- [HP:0000365](http://purl.obolibrary.org/obo/HP_0000365) (Hearing impairment) and [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) 62.50%
- [HP:0000364](http://purl.obolibrary.org/obo/HP_0000364) (Hearing abnormality) and [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and (not ([HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration))) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and (not ([HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis))) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and (not ([HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis))) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and (not ([HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia))) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 62.50%
- [HP:0010964](http://purl.obolibrary.org/obo/HP_0010964) (Abnormality of long-chain fatty-acid metabolism) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 62.50%


